Arginine-Supplemented Diets Improve Survival in Gut-Derived Sepsis and Peritonitis by Modulating Bacterial Clearance The Role of Nitric Oxide
- 1 June 1993
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 217 (6), 644-654
- https://doi.org/10.1097/00000658-199306000-00006
Abstract
The effect of arginine on survival rates and host defense mechanisms was studied using two clinically relevant models of infection that included transfusion-induced immunosuppression. Dietary arginine will improve resistance to infection but its role in transfusion-induced immunosuppression and bacterial translocation (gut-derived sepsis) has not been defined. Balb/c mice were fed for 10 days with either a defined AIN-76A diet, an AIN-76A diet supplemented with 2% arginine, an AIN-76A diet supplemented with 4% glycine, or standard laboratory chow. In most experiments, the mice were then transfused with allogeneic blood and allowed to feed for an additional 5 days before undergoing either cecal ligation and puncture (CLP) or gavage with 10(10) Escherichia coli and a 20% burn injury. Additional animals fed with the arginine supplemented diet were treated with the nitric oxide inhibitor N omega-Nitro-L-arginine (NNA) before gavage and burn. The effect of these diets and NNA on the degree of translocation of 14C-radiolabeled E. coli from the intestine and the ability of the host to kill translocated organisms was also investigated. Mice were fed and received transfusion, gavage, and burn as above. Mesenteric lymph nodes (MLN), liver and spleen were harvested 4 hours postburn. Survival after CLP was 56% in the arginine-supplemented group versus 28% in the AIN-76A group and 20% in the chow group (p < 0.02). After gavage and burn, survival was 100% in the arginine-supplemented group versus 50% in both the glycine-supplemented and chow groups and 35% in the AIN-76A group (p < 0.01). In animals receiving the arginine-supplemented diet, treatment with NNA decreased survival from 95% to 30.5% (p < 0.0001). Greater translocation, as measured by radionuclide counts, was observed to the MLN of the AIN-76A group. However, there was no difference in translocation to the liver and spleen related to dietary group. Quantitative colony counts and the calculated percentage of remaining viable bacteria showed that the ability to kill translocated organisms was significantly enhanced in animals receiving arginine. Treatment with NNA reversed the beneficial effects of arginine on immune defense. The benefit of arginine appears to be mediated by improved bactericidal mechanisms via the arginine-nitric oxide pathway.Keywords
This publication has 46 references indexed in Scilit:
- Reduction of bacterial translocation with oral fibroblast growth factor and sucralfateThe American Journal of Surgery, 1993
- Arginine stimulates lymphocyte immune response in healthy human beings.1981
- A study of growth hormone release in man after oral administration of amino acidsCurrent Medical Research and Opinion, 1981
- Immunostimulatory effects of arginine in normal and injured ratsJournal of Surgical Research, 1980
- Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusionDiabetologia, 1979
- CONTRIBUTIONS OF BILE AND PANCREATIC-JUICE TO CELL-PROLIFERATION IN ILEAL MUCOSA1978
- ARGININE - ESSENTIAL AMINO-ACID FOR INJURED RATS1978
- Experimental Studies of the Pathogenesis of Infections Due to Pseudomonas aeruginosa: Description of a Burned Mouse ModelThe Journal of Infectious Diseases, 1975
- Polyamine synthesis during lymphocyte activation: Induction of ornithine decarboxylase and S-adenosyl methionine decarboxylaseExperimental Cell Research, 1973
- Plasma Growth Hormone after Arginine InfusionNew England Journal of Medicine, 1967